AMR Industry Alliance provides report on members' progress tackling superbugs

A new report from the AMR Industry Alliance, a group of over 100 life sciences firms focused on tackling the public health threat of antimicrobial resistance (AMR), provides an update on the practical steps members have undertaken in this area.

The biennial progress report looks at the areas of research and science, access, appropriate use and the environment, and presents data on AMR-relevant products such as antibiotics and vaccines.

Chairman Thomas Cueni described it as “the first industry-wide grouping of this scale that has been set up to respond to the AMR emergency.”